Matthew G. Bursavich
Publications by Year
Research Areas
Chemical Synthesis and Analysis, Peptidase Inhibition and Analysis, Computational Drug Discovery Methods, Cell Adhesion Molecules Research, Alzheimer's disease research and treatments
Most-Cited Works
- → Designing Non-Peptide Peptidomimetics in the 21st Century: Inhibitors Targeting Conformational Ensembles(2002)208 cited
- → Gamma Secretase Modulators: New Alzheimer’s Drugs on the Horizon?(2016)135 cited
- → 2-Anilino-4-aryl-1,3-thiazole inhibitors of valosin-containing protein (VCP or p97)(2010)60 cited
- → 5-((1H-Pyrazol-4-yl)methylene)-2-thioxothiazolidin-4-one inhibitors of ADAMTS-5(2006)59 cited
- → From Peptides to Non-Peptide Peptidomimetics: Design and Synthesis of New Piperidine Inhibitors of Aspartic Peptidases(2001)53 cited
- → (1-(4-(Naphthalen-2-yl)pyrimidin-2-yl)piperidin-4-yl)methanamine: A Wingless β-Catenin Agonist That Increases Bone Formation Rate(2009)52 cited
- → Synthesis and evaluation of aryl thioxothiazolidinone inhibitors of ADAMTS-5 (Aggrecanase-2)(2006)51 cited
- → 5′-Phenyl-3′H-spiro[indoline-3,2′-[1,3,4]thiadiazol]-2-one inhibitors of ADAMTS-5 (Aggrecanase-2)(2007)51 cited
- → Discovery of Potent and Selective Inhibitors of the Mammalian Target of Rapamycin (mTOR) Kinase(2009)51 cited
- → N-((8-Hydroxy-5-substituted-quinolin-7-yl)(phenyl)methyl)-2-phenyloxy/amino-acetamide inhibitors of ADAMTS-5 (Aggrecanase-2)(2008)50 cited